GE and the Government of Ontario Establish First Global Digital Pathology Centre of Excellence

GEGE announced an agreement to establish its first Global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE and its digital pathology joint venture, Omnyxâ„¢, will invest $7.75M along with a $2.25M grant from the Health Technology Commercialization Program created by HTX (Health Technology Exchange) and funded by the Ontario Ministry of Research and Innovation. Planned collaborative research and development partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

Today's announcement builds on a Memorandum of Understanding (MOU) GE signed with the Ontario government in September 2009 to partner and invest long-term within the province. The Centre's creation will drive research and development, create 15 new innovation-related jobs and facilitate global collaboration.

"Today's announcement is an excellent example of how business and government can partner to develop innovative technologies that address Ontario healthcare challenges while having applicability to patient care globally," noted Elyse Allan, President & CEO, GE Canada.

"The Centre of Excellence is expected to create best practices and develop digital technologies to address critical issues including access to pathologists regardless of where a patient or specialist is located, confidence in pathology services, improved turnaround times and greater collaboration among specialists," said Peter Robertson, Vice President & General Manager of GE Healthcare, Canada.

GE's breakthrough technology extends beyond slide digitization to enable pathology departments to improve the efficiency of the entire pathology process including better communication and collaboration, which could help enhance the quality of patient care. The new centre will open in spring 2011.

About GE
GE is Imagination at Work - a diversified technology, media and financial services company focused on solving some of the world's toughest problems. With products and services ranging from aircraft engines, power generation, water processing and security technology to medical imaging, business and consumer financing, media content and advanced materials, GE serves customers in more than 100 countries and employs more than 300,000 people worldwide.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

About healthymagination
Healthymagination is GE's $6 billion commitment that was launched in May 2009. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world.

About Omnyx
Omnyx, LLC is a joint venture of GE Healthcare and The University of Pittsburgh Medical Center with locations in Pittsburgh, PA and Piscataway, NJ. The company is developing an enterprise platform to transform the scope of pathology to an all-digital workflow. Omnyx will sell its digital pathology platform to clinical labs and offer an enterprise software platform for image management, workflow automation, image analysis algorithms and system integration along with its high speed whole-slide scanners. Close collaboration with pathologists at UPMC and other institutions along with their relationship with GE Healthcare allows Omnyx to focus its innovation on the needs of anatomic pathologists worldwide. Omnyx digital pathology products are currently in development and have not yet been cleared by the US FDA or licensed by Health Canada.

About HTX
From Invention through to Innovation to International Invoice, HTX supports emerging and established Ontario-based companies to develop, produce and commercialize innovative market-leading advanced health technologies. HTX is funded by the Government of Ontario through the Ministry of Research and Innovation.